Senzagen

Senzagen company information, Employees & Contact Information

Updated June 2026

Quick answer

Senzagen is a Biotechnology company and founded in 2010. It has approximately 25 employees on record. Contact data was last refreshed in June 2026. Find Senzagen's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® test platform, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings. SenzaGen has its headquarters and GLP-certified laboratory in Lund, Sweden and subsidiaries in the US and Italy.

Company Details

Employees
25
Founded
2010
Address
Medicon Village, Scheelev. 2,united States
Phone
46 4 62 22 92 56
Email
am****@****gen.com
Industry
Biotechnology
HQ
Lund, Skåne
Looking for a particular Senzagen employee's phone or email?

Senzagen Questions

News

SenzaGen invites to Capital Markets Day in Stockholm on November 10, 2025 - Finansavisen

SenzaGen invites to Capital Markets Day in Stockholm on November 10, 2025 Finansavisen

SenzaGen obtains expanded OECD approval for GARD®skin – further strengthens position in non-animal regulatory testing - Finansavisen

SenzaGen obtains expanded OECD approval for GARD®skin – further strengthens position in non-animal regulatory testing Finansavisen

Evaluation of the applicability of GARDskin to predict skin sensitizers in extracts from medical device materials - Frontiers

Evaluation of the applicability of GARDskin to predict skin sensitizers in extracts from medical device materials Frontiers

SenzaGen gets new funding to boost non-animal testing methods - Cosmetics Design Europe

SenzaGen gets new funding to boost non-animal testing methods Cosmetics Design Europe

SenzaGen’s interim report January–June 2025 | Strong order intake and expanded OECD approval for GARD®skin - Finansavisen

SenzaGen’s interim report January–June 2025 | Strong order intake and expanded OECD approval for GARD®skin Finansavisen

Finally, a test for respiratory chemical allergy | GARDair Project | Results in Brief | H2020 - CORDIS

Finally, a test for respiratory chemical allergy | GARDair Project | Results in Brief | H2020 CORDIS

BIOGLAN LOGO - Cision News

BIOGLAN LOGO Cision News

SenzaGen receives new assignment worth 1.5 MSEK from RIFM for continued collaboration in photosensitization testing - Finansavisen

SenzaGen receives new assignment worth 1.5 MSEK from RIFM for continued collaboration in photosensitization testing Finansavisen

Top Senzagen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant